» Articles » PMID: 25417195

IL-33 Expression in the Cerebral Cortex Following Experimental Subarachnoid Hemorrhage in Rats

Overview
Publisher Springer
Date 2014 Nov 24
PMID 25417195
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Subarachnoid hemorrhage (SAH) is a pervasive and devastating condition in which inflammatory and apoptotic pathways contribute to poor outcome. Interleukin-33 (IL-33) plays a crucial role in the inflammatory and apoptotic pathways through binding of the transmembrane ST2 receptor. This study investigated the expression and cellular localization of IL-33 in the cerebral cortex after SAH in order to clarify the role of IL-33 after SAH. Sprague-Dawley rats were randomly divided into sham and SAH groups and evaluated 2, 6, and 12 h and 1, 2, 3, and 5 days after the surgery, with SAH animals subjected to prechiasmatic cistern SAH. IL-33 expression was measured by western blot analysis, real-time PCR, immunohistochemistry, and immunofluorescence. The mRNA levels of tumor necrosis factor (TNF)-α and IL-1β were also assessed. The expression of IL-33, IL-1β, and TNF-α was markedly elevated in the SAH as compared to the sham group; IL-33 was mainly localized in neurons and astrocytes and not microglia after SAH. Moreover, a significant positive association was observed between IL-33 and IL-1β expression. These findings indicate that IL-33 might play an important role in the inflammatory response following SAH.

Citing Articles

CDDO, an Anti-Inflammatory and Antioxidant Compound, Attenuates Vasospasm and Neuronal Cell Apoptosis in Rats Subjected to Experimental Subarachnoid Hemorrhage.

Winardi W, Lo Y, Tsai H, Huang Y, Tseng T, Chung C Curr Issues Mol Biol. 2024; 46(5):4688-4700.

PMID: 38785551 PMC: 11119475. DOI: 10.3390/cimb46050283.


All Three Supersystems-Nervous, Vascular, and Immune-Contribute to the Cortical Infarcts After Subarachnoid Hemorrhage.

Dreier J, Joerk A, Uchikawa H, Horst V, Lemale C, Radbruch H Transl Stroke Res. 2024; 16(1):96-118.

PMID: 38689162 PMC: 11772491. DOI: 10.1007/s12975-024-01242-z.


Therapeutic Effect of Mitochondrial Division Inhibitor-1 (Mdivi-1) on Hyperglycemia-Exacerbated Early and Delayed Brain Injuries after Experimental Subarachnoid Hemorrhage.

Chung C, Huang Y, Lin C, Chong Y, Wu S, Chai C Int J Mol Sci. 2022; 23(13).

PMID: 35805932 PMC: 9267000. DOI: 10.3390/ijms23136924.


The blood-brain barrier and the neurovascular unit in subarachnoid hemorrhage: molecular events and potential treatments.

Solar P, Zamani A, Lakatosova K, Joukal M Fluids Barriers CNS. 2022; 19(1):29.

PMID: 35410231 PMC: 8996682. DOI: 10.1186/s12987-022-00312-4.


A Systematic Review of Inflammatory Cytokine Changes Following Aneurysmal Subarachnoid Hemorrhage in Animal Models and Humans.

Devlin P, Ishrat T, Grimes Stanfill A Transl Stroke Res. 2022; 13(6):881-897.

PMID: 35260989 DOI: 10.1007/s12975-022-01001-y.


References
1.
Yasuoka S, Kawanokuchi J, Parajuli B, Jin S, Doi Y, Noda M . Production and functions of IL-33 in the central nervous system. Brain Res. 2011; 1385:8-17. DOI: 10.1016/j.brainres.2011.02.045. View

2.
Sehba F, Pluta R, Zhang J . Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injury. Mol Neurobiol. 2010; 43(1):27-40. PMC: 3023855. DOI: 10.1007/s12035-010-8155-z. View

3.
Loch Macdonald R, Pluta R, Zhang J . Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution. Nat Clin Pract Neurol. 2007; 3(5):256-63. DOI: 10.1038/ncpneuro0490. View

4.
Jiang H, Milovanovic M, Allan D, Niedbala W, Besnard A, Fukada S . IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages. Eur J Immunol. 2012; 42(7):1804-14. DOI: 10.1002/eji.201141947. View

5.
Jeon H, Ai J, Sabri M, Tariq A, Macdonald R . Learning deficits after experimental subarachnoid hemorrhage in rats. Neuroscience. 2010; 169(4):1805-14. DOI: 10.1016/j.neuroscience.2010.06.039. View